Birzeit Pharmaceuticals Company Share Price Palestine Exchange
Equities
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- | - |
02-25 | Birzeit Pharmaceuticals Company Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01-09 | What does the Gotham City report say about Grifols? | RE |
Sales 2022 | 47.03M 0 3.71B | Sales 2023 | 43.13M 0 3.4B | Capitalization | 169M 0 13.35B |
---|---|---|---|---|---|
Net income 2022 | 7M - 551M | Net income 2023 | 6M - 473M | EV / Sales 2022 | 3.31 x |
Net cash position 2022 | 15.41M 0 1.21B | Net cash position 2023 | 17.19M 0 1.35B | EV / Sales 2023 | 3.53 x |
P/E ratio 2022 |
21.5
x | P/E ratio 2023 |
27.3
x | Employees | - |
Yield 2022 |
2.27% | Yield 2023 |
-
| Free-Float | 73.92% |
Managers | Title | Age | Since |
---|---|---|---|
Talal Nasereddin
CEO | Chief Executive Officer | 74 | 31/03/84 |
Director of Finance/CFO | - | 14/11/84 | |
Chief Tech/Sci/R&D Officer | - | 31/01/97 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 31/12/20 | |
Chief Administrative Officer | 54 | 31/12/91 | |
Talal Nasereddin
CEO | Chief Executive Officer | 74 | 31/03/84 |
1st Jan change | Capi. | |
---|---|---|
+21.28% | 44.4B | |
+24.47% | 23.03B | |
+19.22% | 15.14B | |
+12.87% | 13.12B | |
+44.67% | 11.85B | |
-9.92% | 6.99B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.07% | 5.52B |